2009 Violations In Feb 2009, the FDA halted a review of importation applications for generic drugs manufactured at Ranbaxy's Paonta Sahib plant owned by Ranbaxy Laboratories, LTD, the Indian generic drug manufacturer, "due to evidence of … [Read more...]